LEADER 01435nam  2200385Ia 450 
001 9910697092403321
005 20230902161549.0
035   $a(CKB)5470000002383974
035   $a(OCoLC)587672194
035   $a(EXLCZ)995470000002383974
100   $a20100330d2008      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eacute bacterial exacerbations of chronic bronchitis in patients with chronic obstructive pulmonary disease : developing antimicrobial drugs for treatment
205   $aRevision 1.
210  1$aSilver Spring, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2008]
215   $a1 electronic resource (20 pages)
300   $a"Draft guidance."
300   $a"Clinical antimicrobial."
300   $a"August 2008."
517   $aGuidance for industry 
606   $aAnti-infective agents$xDevelopment$zUnited States
606   $aLungs$xDiseases, Obstructive$zUnited States
615  0$aAnti-infective agents$xDevelopment
615  0$aLungs$xDiseases, Obstructive
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697092403321
996   $aGuidance for industry$93434577
997   $aUNINA